Astrana Health

ASTH · NASDAQ

$38.58+$1.68 (+4.55%)TodayMarket closed ·
Prev close $36.90

Latest news

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseBusiness Wire

    Verda Healthcare, Inc. and AstranaCare Partners Form a Multi-State Partnership

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2026 Third Quarter Financial Results Release and Conference Call

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc. - ASTH

  • Press releaseBusiness Wire

    ASTH Investors Have Opportunity to Join Astrana Health, Inc. Fraud Investigation with SBS Law

  • Press releasePRNewswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseGlobe Newswire

    INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Astrana Health, Inc.- ASTH

  • Press releaseGlobe Newswire

    Lowey Dannenberg, P.C. is Investigating Astrana Health, Inc. (NASDAQ: ASTH) for Potential Violations of the Federal Securities Laws

  • News

    Astrana Health Q2 EPS $0.40 Beats $0.34 Estimate, Sales $972.520M Miss $985.716M Estimate

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Second Quarter 2026 Results

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2026 Second Quarter Financial Results Release and Conference Call

  • Press releasePRNewswire

    Astrana Health Strengthens Leadership Team to Accelerate Long-Term Growth

  • Press releasePRNewswire

    Astrana Health ACOs Deliver $120.4 Million in Gross Shared Savings in 2024 Performance Year

  • Press releasePRNewswire

    Astrana Health Named to the 2026 Fortune 1000 List Following Strong Revenue Growth

  • Press releasePRNewswire

    Astrana Health, Inc. Announces Appointment of Interim National Medical Director

  • Press releasePRNewswire

    Physician Association of California and Astrana Health Launch Collaboration to Strengthen Independent Primary Care

  • News

    Astrana Health Q1 EPS $0.29 Misses $0.30 Estimate, Sales $965.100M Beat $949.206M Estimate

  • Press releasePRNewswire

    Astrana Health, Inc. Reports First Quarter 2026 Results

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2026 First Quarter Financial Results Release and Conference Call

  • Press releasePRNewswire

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

  • NewsVandana Singh

    UnitedHealth, Humana, CVS Jump As CMS Boosts Medicare Payments

  • Press releasePRNewswire

    Foothill Regional Medical Center Receives 2026 Patient Safety Excellence Award™ from Healthgrades

  • Press releasePRNewswire

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    US Stocks Mixed Amid War Against Iran: Investor Sentiment Improves, But Greed Index Remains In 'Fear' Zone

  • NewsAvi Kapoor

    Crude Oil Rises Sharply; Sealed Air Posts Upbeat Earnings

  • News

    12 Health Care Stocks Moving In Monday's Intraday Session

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Fourth Quarter and Year End 2025 Results

  • News

    Earnings Outlook For Astrana Health

  • News

    6 Analysts Assess Astrana Health: What You Need To Know

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2025 Fourth Quarter and Year-End Financial Results Release and Conference Call

  • Press releasePRNewswire

    Astrana Health, Inc. to Participate in Upcoming Investor Conference

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Third Quarter 2025 Results

  • News

    Earnings Scheduled For November 6, 2025

  • Press releasePRNewswire

    Astrana Health, Inc. Schedules 2025 Third Quarter Financial Results Release and Conference Call

  • Press releasePRNewswire

    Astrana Health, Inc. to Participate in Upcoming Investor Conferences

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Second Quarter 2025 Results

  • Press releasePRNewswire

    Doctors Are Being Outpaced by AI-Powered Algorithms -- Here's What It Means for Investors

  • Press releasePRNewswire

    Astrana Health, Inc. Reports First Quarter 2025 Results

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

  • Press releasePRNewswire

    Astrana Health Announces Definitive Agreement to Acquire Certain Businesses and Assets of Prospect Health System

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Third Quarter 2024 Results

  • Press releasePRNewswire

    Astrana Health, Inc. Reports Second Quarter 2024 Results

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.